Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • Biotechnology
  • Evaxion scraps solid tumor vaccine to focus on Duke-partnered brain cancer candidate

Evaxion scraps solid tumor vaccine to focus on Duke-partnered brain cancer candidate

August 17, 2026Posted inBiotechnology

Evaxion has scrapped a next-gen solid tumor vaccine in order to channel resources to a candidate specifically targeting brain cancer.

Post navigation

Previous Post
malaria-causing-plasmodium-in-uganda-show-rapid-spread-of-drug-resistance-mutations Malaria-Causing Plasmodium in Uganda Show Rapid Spread of Drug Resistance Mutations
Next Post
Slate uses Fulcrum to vault onto Nasdaq with $245M financing for migraine trials

Recent Posts

  • Excessively Dilated Kidneys Face Higher Surgical Risks in Children
  • Cancer cells evade death via network-level plasticity
  • ARL6IP4 Linked to Osteoarthritis in Activated T Cells
  • Language Models Show High Consistency and Divergent Profiles Across Personality Assessments
  • Social Matrix Framework Links Heritage Tree Persistence to Interconnected Community Stewardship Systems

Archives

  • November 2026
  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • September 2024
  • August 2024
  • March 2024
  • September 2023

Privacy Policy    Terms

Scroll to Top